Clinical Trial

Fecal Microbiota Transplantation for Radiation-Induced Proctopathy

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated March 10, 2025 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this single-arm trial is to learn if Fecal Microbiota Transplantation (FMT) works to treat hemorrhagic radiation-induced proctopathy. The main questions it aims to answer are: * Dose FMT alleviate the symptom of severe rectal bleeding? * Dose FMT improve the endoscopic findings of proctopathy? Participants will: * Take fecal microbiota capsules by 8 sessions over a 12-week period. * Visit the clinic once every 4 weeks for checkups and tests. * Keep a diary of their symptoms and the number of times they use other supportive care.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-10.
Status change: Not Yet Recruiting → Recruiting 2025-03-05
Trial Details
NCT Number NCT06776029
Lead Sponsor Sixth Affiliated Hospital, Sun Yat-sen University
Conditions Radiation Induced Proctitis
Enrollment 20 participants
Start Date 2025-02-01
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-10